We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

9 hedge funds and large institutions have $321K invested in Decoy Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

73% more capital invested

Capital invested by funds: $186K → $321K (+$135K)

29% more funds holding

Funds holding: 7 → 9 (+2)

0% more ownership

Funds ownership: 0% → 0% (+0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$174K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$16K
3
TRCT
Tower Research Capital (TRC)
New York
+$13.7K
4
JP Morgan Chase
JP Morgan Chase
New York
+$2.29K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$19.8K
2
UBS Group
UBS Group
Switzerland
-$2.29K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$2.29K

DCOY Hedge Fund Activity: Q2 2023 in Review

9 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q2 2023, worth a combined $321K — up 73% from $186K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DCOY positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $174K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $19.8K sold.

  • 9 institutional investors held Decoy Therapeutics (DCOY) as of Q2 2023, up from 7 in Q1 2023.
  • Funds reported $321K of Decoy Therapeutics stock for Q2 2023, up 73% quarter-over-quarter.
  • 4 funds opened new Decoy Therapeutics positions in Q2 2023 and 2 closed out, a net change of +2 holders.
  • The largest Decoy Therapeutics buyer in Q2 2023 was Armistice Capital, an estimated $174K added.
  • The largest Decoy Therapeutics seller in Q2 2023 was Two Sigma Investments, an estimated $19.8K sold.

Based on aggregated 13F filings for Q2 2023.